Novartis AG 0K9E.L Stock
Novartis AG Price Chart
Novartis AG 0K9E.L Financial and Trading Overview
| Novartis AG stock price | 94.11 USD |
| Previous Close | 99.72 USD |
| Open | 0 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 111.55 USD |
| Volume | 185 USD |
| Avg. Volume | 103.37K USD |
| Market Cap | 2.3B USD |
| Beta (5Y Monthly) | 0.47318 |
| PE Ratio (TTM) | 0.09439847 |
| EPS (TTM) | 10.73 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0K9E.L Valuation Measures
| Enterprise Value | 2.11T USD |
| Trailing P/E | 0.09439847 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.04402303 |
| Price/Book (mrq) | 40.811813 |
| Enterprise Value/Revenue | 40.395 |
| Enterprise Value/EBITDA | 113.456 |
Trading Information
Novartis AG Stock Price History
| Beta (5Y Monthly) | 0.47318 |
| 52-Week Change | 25.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 111.55 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 99.76 USD |
| 200-Day Moving Average | 88.34 USD |
0K9E.L Share Statistics
| Avg. Volume (3 month) | 103.37K USD |
| Avg. Daily Volume (10-Days) | 314.72K USD |
| Shares Outstanding | 2.31B |
| Float | 20.06B |
| Short Ratio | N/A |
| % Held by Insiders | 0.0069% |
| % Held by Institutions | 8.24% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 3.461 |
| Trailing Annual Dividend Yield | 3.47% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 13.45% |
| Operating Margin (ttm) | 25.46% |
| Gross Margin | 71.16% |
| EBITDA Margin | 35.60% |
Management Effectiveness
| Return on Assets (ttm) | 7.00% |
| Return on Equity (ttm) | 12.35% |
Income Statement
| Revenue (ttm) | 52.22B USD |
| Revenue Per Share (ttm) | 2.43 USD |
| Quarterly Revenue Growth (yoy) | 3.10% |
| Gross Profit (ttm) | 36.74B USD |
| EBITDA | 18.59B USD |
| Net Income Avi to Common (ttm) | 7.03B USD |
| Diluted EPS (ttm) | 10.731 |
| Quarterly Earnings Growth (yoy) | 3.20% |
Balance Sheet
| Total Cash (mrq) | 12.19B USD |
| Total Cash Per Share (mrq) | 0.58 USD |
| Total Debt (mrq) | 29.2B USD |
| Total Debt/Equity (mrq) | 56.01 USD |
| Current Ratio (mrq) | 1.051 |
| Book Value Per Share (mrq) | 2.4821 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 15.54B USD |
| Levered Free Cash Flow (ttm) | 11.48B USD |
Profile of Novartis AG
| Country | United Kingdom |
| State | N/A |
| City | Basel |
| Address | Lichtstrasse 35 |
| ZIP | 4056 |
| Phone | 41 61 324 1111 |
| Website | https://www.novartis.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 103000 |
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.
Q&A For Novartis AG Stock
What is a current 0K9E.L stock price?
Novartis AG 0K9E.L stock price today per share is 94.11 USD.
How to purchase Novartis AG stock?
You can buy 0K9E.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novartis AG?
The stock symbol or ticker of Novartis AG is 0K9E.L.
How many shares does Novartis AG have in circulation?
The max supply of Novartis AG shares is 22.69M.
What is Novartis AG Price to Earnings Ratio (PE Ratio)?
Novartis AG PE Ratio is 0.08769919 now.
What was Novartis AG earnings per share over the trailing 12 months (TTM)?
Novartis AG EPS is 10.73 USD over the trailing 12 months.